INTELLIGENT BIO SOLUTIONS INC. Research and Development Expense
INTELLIGENT BIO SOLUTIONS INC. (INBS) reported Research and Development Expense of $341.82 thousand for the 3-month period ending 2020-12-31, per its 10-Q filed 2021-02-12.
Discontinued › Expense Statement › Operating Expenses
us-gaap:ResearchAndDevelopmentExpense · last filed 2021-02-12
- INTELLIGENT BIO SOLUTIONS INC. research and development expense for the quarter ending 2020-12-31 was $341.82K, a 30.90% decline year-over-year.
- INTELLIGENT BIO SOLUTIONS INC. research and development expense for the quarter ending 2019-12-31 was $494.67K.
| Period end | Research and Development Expense 3 month | Research and Development Expense 6 month |
|---|---|---|
| 2020-12-31 | $341.82K 10-Q · filed 2021-02-12 | $372.76K 10-Q · filed 2021-02-12 |
| 2019-12-31 | $494.67K 10-Q · filed 2021-02-12 | $599.85K 10-Q · filed 2021-02-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Sonoma Pharmaceuticals, Inc. (SNOA) | United States | $0.006B | -2.59 |
| AETHLON MEDICAL INC (AEMD) | United States | $0.005B | |
| enVVeno Medical Corp (NVNO) | United States | $0.006B | -0.48 |
| Bluejay Diagnostics, Inc. (BJDX) | United States | $0.004B | |
| OSR Health, Inc. (OSRH) | United States | $0.004B | -0.75 |
| Adagio Medical Holdings, Inc. (ADGM) | United States | $0.004B | |
| Autonomix Medical, Inc. (AMIX) | United States | $0.004B | |
| Co-Diagnostics, Inc. (CODX) | United States | $0.007B | -0.32 |
| Beyond Air, Inc. (XAIR) | United States | $0.003B | -0.01 |
| Vivos Therapeutics, Inc. (VVOS) | United States | $0.003B | -0.26 |